Soleus Capital Management, L.P. Jasper Therapeutics, Inc. Call Options Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding JSPR
# of Institutions
1Shares Held
5.63MCall Options Held
0Put Options Held
0About Jasper Therapeutics, Inc.
- Ticker JSPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,073,300
- Market Cap $806M
- Description
- Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...